Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...

Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

In order to produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic ...

Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of ...

University of Kentucky Markey Cancer Center researcher Weisi Yan, M.D., Ph.D., recently shared his work on radiation therapy at a major international conference, showcasing how new techniques could ...

Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.

Mayo Clinic researchers say they have identified why some cancer patients relapse after receiving CAR-T cell therapy. The study, published in Molecular Cancer, reveals that the engineered immune cells ...

Cancer therapies called checkpoint inhibitor drugs, which ratchet up the immune system, work better when this bacterium is ...

Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...